Try our Advanced Search for more refined results
New Jersey - May, 2007
45 articles
- NJ Judge Certifies Wal-Mart Employee Class Action
- Cordis Gets New Stent Patent, Sues Abbott
- Becton Dickinson Seeks More Time In Antitrust Suit
- Roche Loses First Accutane Trial, Jury Awards $2.5M
- States Consider Law Against Office Bullies
- Congoleum Heads Back To Negotiating Table
- Whistleblower Suit Against Schering To Proceed
- Marcal's Proposed Hires Raise Objections
- Judge Throws Out Slew Of Cases Against Pfizer
- Class Certified In ERISA Case Vs. HSBC
- State Supreme Court Spurns Citigroup Request
- Altana, Sun Squabble Over Discovery Motions
- Ortho Evra Cases Consolidated In Ohio
- California Will Sue If EPA Denies Waiver Request
- Calpine Asks To Take Over Power Plant
- Insurers Off The Hook In Congoleum Settlement
- Sea Containers Asks For Extension To File Plan
- Gas Cos. Move To Consolidate Temperature Suits
- Court Lifts Order Barring Teva's Generic Lotrel
- AstraZeneca Sued Over Seroquel Promotions
- States Step Up Vigilance Of Energy Mergers
- Taking The Ostrich's Head Out Of The Sand
- Advisors, Attorneys Get Paid In Marcal Case
- SEC Adds Defendant In NJ Affordable Case
- Abbott Wants New J&J Stent Patent Declared Invalid
- Ex-Oppenheimer Exec Pleads Guilty To Stock Fraud
- Merck Files Second Suit Against Teva Over Singulair
- Sanofi-Aventis Sues To Protect Ambien Market
- Abbott Sues To Protect Depakote ER
- Roche Workers Lose Appeal Of ERISA Claims
- Geico Denies Adjustors' Claims In Wage Suits
- Judge Rejects Congoleum's $25M Pact With Insurers
- Hess Sued Under Fair Credit Reporting Act
- Railroad Freight Haulers Accused Of Price-Fixing
- California Blames Govt. For Weak Fuel Standards
- J&J Keeps Cheap Risperdal Off Shelves
- SEC Probes Hedge Funds' Short-Selling Claims
- EU Court Shakes Head At SGL Carbon's Appeal
- House Debates Subprime Industry Regulation
- Class Certified In Harrah's Employee Options Case
- Brazil Breaks Patent On Merck's AIDS Drug
- Attorney-Client Privilege And Health Insurers
- ERISA Suit Against AT&T, Lucent Dismissed
- FDA Gives Mylan Tentative OK On Generic Femara
- Canadian Court Blocks Generic Celebrex Launch